Literature DB >> 12643562

Economic, legal, and ethical rationales for the ACRIN national lung screening trial of CT screening for lung cancer.

Bruce J Hillman1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12643562     DOI： 10.1016/s1076-6332(03)80115-0

Source DB:  PubMed          Journal:  Acad Radiol        ISSN： 1076-6332            Impact factor:   3.173


× No keyword cloud information.
  9 in total

1.  Pulmonary nodule characterization: a comparison of conventional with quantitative and visual semi-quantitative analyses using contrast enhancement maps.

Authors:  Iva Petkovska; Sumit K Shah; Michael F McNitt-Gray; Jonathan G Goldin; Matthew S Brown; Hyun J Kim; Kathleen Brown; Denise R Aberle
Journal:  Eur J Radiol       Date:  2006-04-17       Impact factor: 3.528

2.  Computed tomography assessment of response to therapy: tumor volume change measurement, truth data, and error.

Authors:  Michael F McNitt-Gray; Luc M Bidaut; Samuel G Armato; Charles R Meyer; Marios A Gavrielides; Charles Fenimore; Geoffrey McLennan; Nicholas Petrick; Binsheng Zhao; Anthony P Reeves; Reinhard Beichel; Hyun-Jung Grace Kim; Lisa Kinnard
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

3.  CT quality assurance in the lung screening study component of the National Lung Screening Trial: implications for multicenter imaging trials.

Authors:  David S Gierada; Kavita Garg; Hrudaya Nath; Diane C Strollo; Richard M Fagerstrom; Melissa B Ford
Journal:  AJR Am J Roentgenol       Date:  2009-08       Impact factor: 3.959

4.  Screening in the dark: ethical considerations of providing screening tests to individuals when evidence is insufficient to support screening populations.

Authors:  Ingrid M Burger; Nancy E Kass
Journal:  Am J Bioeth       Date:  2009-04       Impact factor: 11.229

5.  Imaging technology and practice assessments: what next?

Authors:  David Gur
Journal:  Acad Radiol       Date:  2009-05       Impact factor: 3.173

6.  Satisfaction of search from detection of pulmonary nodules in computed tomography of the chest.

Authors:  Kevin S Berbaum; Kevin M Schartz; Robert T Caldwell; Mark T Madsen; Brad H Thompson; Brian F Mullan; Andrew N Ellingson; Edmund A Franken
Journal:  Acad Radiol       Date:  2012-10-26       Impact factor: 3.173

7.  Collecting 48,000 CT exams for the lung screening study of the National Lung Screening Trial.

Authors:  Kenneth W Clark; David S Gierada; Guillermo Marquez; Stephen M Moore; David R Maffitt; Joan D Moulton; Mary A Wolfsberger; Paul Koppel; Stanley R Phillips; Fred W Prior
Journal:  J Digit Imaging       Date:  2008-09-06       Impact factor: 4.056

8.  The Reference Image Database to Evaluate Response to therapy in lung cancer (RIDER) project: a resource for the development of change-analysis software.

Authors:  S G Armato; C R Meyer; M F Mcnitt-Gray; G McLennan; A P Reeves; B Y Croft; L P Clarke
Journal:  Clin Pharmacol Ther       Date:  2008-10       Impact factor: 6.875

9.  Diagnostic classification of solitary pulmonary nodules using dual time 18F-FDG PET/CT image texture features in granuloma-endemic regions.

Authors:  Song Chen; Stephanie Harmon; Timothy Perk; Xuena Li; Meijie Chen; Yaming Li; Robert Jeraj
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.